| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 2575923 | The American Journal of Geriatric Pharmacotherapy | 2009 | 10 Pages | 
Abstract
												Conclusions: Overall, solifenacin was found to improve symptom bother, HRQoL, work productivity, activity participation, and reduced medical care resource utilization in these elderly subjects with OAB who continued to have urgency symptoms with tolterodine and were willing to try solifenacin. This was an exploratory subgroup analysis of an open-label, noncomparative study; further research is needed to confirm these results.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Geriatrics and Gerontology
												
											Authors
												Norman MD, Les MPA, Lawrence MPH, Thomas PharmD, M. PharmD, Raafat PhD, 
											